Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aptos (APT) vs Bio Protocol (BIO) Price & Performance

Aptos
Bio Protocol

Price performance

Price movement over the last 24 hours

Key statistics

Aptos vs Bio Protocol — how do they compare? Aptos trades at Rp11,162 (market cap Rp9,38T, Rp1,3T 24h volume), while Bio Protocol trades at Rp496.69 (market cap Rp1,11T, Rp317,28M 24h volume). The key difference: Aptos is far larger — about 8.5× Bio Protocol's market cap, and Aptos's circulating supply is 833M / 2,1B APT (40%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 31 Days and Bio Protocol for 16 Days on average.

APTBIO
Market Cap
Rp9,38TRp1,11T
Volume (24h)
Rp1,3TRp317,28M
Circulating Supply
833M / 2,1B APT (40%)2,2B / 3,3B BIO (68%)
Typical Hold Time
31 Days16 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aptos

Aptos trades at Rp11,163 with a market cap of Rp9.38T, showing neutral technical signals overall. The asset is currently between key support at Rp11,027 and resistance at Rp11,614, with mixed indicator readings - RSI_6 suggests overbought conditions while ADX_6 indicates strong trend strength. With 40% of max supply circulating and average hold time of 31 days, token distribution appears stable.

Outlook remains balanced with technical indicators showing conflicting signals. Key opportunities include potential breakout above Rp11,614 resistance, while risks include overbought RSI conditions and broader crypto market volatility. Investors should monitor volume patterns and ecosystem developments closely.

Bio Protocol

Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.

Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

APT
19% Buy81% Sell
Avg holding period · 31 Days
BIO
67% Buy33% Sell
Avg holding period · 16 Days

Top news

Latest headlines on both assets

About Aptos

Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.

Read more on APT

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO